Follow
Rika Maruyama
Title
Cited by
Cited by
Year
Eteplirsen in the treatment of Duchenne muscular dystrophy
KRQ Lim, R Maruyama, T Yokota
Drug design, development and therapy, 533-545, 2017
4662017
Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy
Y Echigoya, A Nakamura, T Nagata, N Urasawa, KRQ Lim, N Trieu, ...
Proceedings of the National Academy of Sciences 114 (16), 4213-4218, 2017
1042017
EGG-3 regulates cell-surface and cortex rearrangements during egg activation in Caenorhabditis elegans
R Maruyama, NV Velarde, R Klancer, S Gordon, P Kadandale, JM Parry, ...
Current Biology 17 (18), 1555-1560, 2007
892007
EGG-4 and EGG-5 link events of the oocyte-to-embryo transition with meiotic progression in C. elegans
JM Parry, NV Velarde, AJ Lefkovith, MH Zegarek, JS Hang, J Ohm, ...
Current Biology 19 (20), 1752-1757, 2009
822009
Quantitative antisense screening and optimization for exon 51 skipping in Duchenne muscular dystrophy
Y Echigoya, KRQ Lim, N Trieu, B Bao, BM Nichols, MC Vila, JS Novak, ...
Molecular Therapy 25 (11), 2561-2572, 2017
772017
Drosophila as a model for epithelial tube formation
R Maruyama, DJ Andrew
Developmental Dynamics, 2011
752011
Comparison of the phenotypes of patients harboring in-frame deletions starting at exon 45 in the Duchenne muscular dystrophy gene indicates potential for the development of …
A Nakamura, N Shiba, D Miyazaki, H Nishizawa, Y Inaba, N Fueki, ...
Journal of human genetics 62 (4), 459-463, 2017
622017
Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background
M Rodrigues, Y Echigoya, R Maruyama, KRQ Lim, S Fukada, T Yokota
Scientific reports 6 (1), 38371, 2016
502016
Nusinersen in the treatment of spinal muscular atrophy
K Goodkey, T Aslesh, R Maruyama, T Yokota
Exon skipping and inclusion therapies: Methods and protocols, 69-76, 2018
492018
LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts
A Touznik, R Maruyama, K Hosoki, Y Echigoya, T Yokota
Scientific reports 7 (1), 3672, 2017
492017
Inhibition of DUX4 expression with antisense LNA gapmers as a therapy for facioscapulohumeral muscular dystrophy
KRQ Lim, R Maruyama, Y Echigoya, Q Nguyen, A Zhang, H Khawaja, ...
Proceedings of the National Academy of Sciences 117 (28), 16509-16515, 2020
482020
Skipping multiple exons to treat DMD—promises and challenges
T Aslesh, R Maruyama, T Yokota
Biomedicines 6 (1), 1, 2018
452018
Exons 45–55 skipping using mutation-tailored cocktails of antisense morpholinos in the DMD gene
Y Echigoya, KRQ Lim, D Melo, B Bao, N Trieu, Y Mizobe, R Maruyama, ...
Molecular Therapy 27 (11), 2005-2017, 2019
422019
Designing effective antisense oligonucleotides for exon skipping
T Shimo, R Maruyama, T Yokota
Duchenne Muscular Dystrophy: Methods and Protocols, 143-155, 2018
392018
Organ-specific gene expression: the bHLH protein Sage provides tissue specificity to Drosophila FoxA
RM Fox, A Vaishnavi, R Maruyama, DJ Andrew
Development 140 (10), 2160-2171, 2013
392013
Identification of novel antisense-mediated exon skipping targets in DYSF for therapeutic treatment of dysferlinopathy
JJA Lee, R Maruyama, W Duddy, H Sakurai, T Yokota
Molecular Therapy-Nucleic Acids 13, 596-604, 2018
342018
Caenorhabditis elegans DAZ-1 is expressed in proliferating germ cells and directs proper nuclear organization and cytoplasmic core formation during oogenesis
R Maruyama, S Endo, A Sugimoto, M Yamamoto
Developmental Biology 277 (1), 142-154, 2005
332005
Knocking down long noncoding RNAs using antisense oligonucleotide gapmers
R Maruyama, T Yokota
Gapmers: methods and protocols, 49-56, 2020
302020
Efficacy of multi-exon skipping treatment in Duchenne muscular dystrophy dog model neonates
KRQ Lim, Y Echigoya, T Nagata, M Kuraoka, M Kobayashi, Y Aoki, ...
Molecular Therapy 27 (1), 76-86, 2019
272019
Development of DG9 peptide-conjugated single-and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy
KRQ Lim, S Woo, D Melo, Y Huang, K Dzierlega, MNA Shah, T Aslesh, ...
Proceedings of the National Academy of Sciences 119 (9), e2112546119, 2022
252022
The system can't perform the operation now. Try again later.
Articles 1–20